MedTrace Logo

Chitosan Chewing Gum Study in Dialysis Patients

NCT01770470 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2021-06-23

No results posted yet for this study

Summary

The purpose of the pilot study is to determine the impact of short-term administration of chitosan-containing chewing gum on phosphate levels in patients with elevated serum phosphate levels.

Conditions

Interventions

DIETARY_SUPPLEMENT

Chitosan

The product chitosan is contained in a chewing gum formulation

Sponsors & Collaborators

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Thomas Dowling, PhD · University of Maryland, Baltimore

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2010-12-31
Completion
2011-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01770470 on ClinicalTrials.gov